Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation

The Journal of Pharmacology and Experimental Therapeutics
Robbie L McLeodSanjiv Shah

Abstract

We leveraged a clinical pharmacokinetic (PK)/pharmacodynamics (PD)/efficacy relationship established with an oral phosphatidylinositol 3-kinase (PI3K)δ inhibitor (Idelalisib) in a nasal allergen challenge study to determine whether a comparable PK/PD/efficacy relationship with PI3Kδ inhibitors was observed in preclinical respiratory models of type 2 T helper cell (TH2) and type 1 T helper cell (TH1) inflammation. Results from an in vitro rat blood basophil (CD63) activation assay were used as a PD biomarker. IC50 values for PI3Kδ inhibitors, MSD-496486311, MSD-126796721, Idelalisib, and Duvelisib, were 1.2, 4.8, 0.8, and 0.5 μM. In the ovalbumin Brown Norway TH2 pulmonary inflammation model, all PI3Kδ inhibitors produced a dose-dependent inhibition of bronchoalveolar lavage eosinophils (maximum effect between 80% and 99%). In a follow-up experiment designed to investigate PK attributes [maximum (or peak) plasma concentration (Cmax), area under the curve (AUC), time on target (ToT)] that govern PI3Kδ efficacy, MSD-496486311 [3 mg/kg every day (QD) and 100 mg/kg QD] produced 16% and 93% inhibition of eosinophils, whereas doses (20 mg/kg QD, 10 mg/kg twice per day, and 3 mg/kg three times per day) produced 54% to 66% inhibition. O...Continue Reading

References

Mar 1, 1995·Journal of Applied Physiology·H TsukagoshiK F Chung
Sep 13, 2000·Journal of Toxicology and Environmental Health. Part a·D J BassettH Yang
May 16, 2002·Molecular Immunology·S Romagnani
Aug 29, 2002·Clinical and Experimental Immunology·M N HylkemaW Timens
Mar 30, 2004·Biochemical Society Transactions·P M Finan, M J Thomas
May 12, 2004·Current Opinion in Immunology·David A Fruman
Nov 17, 2004·Clinical and Experimental Immunology·L ChenL S Chan
Jun 8, 2006·European Journal of Pharmacology·Chander S CellyRichard W Chapman
Dec 16, 2006·American Journal of Respiratory and Critical Care Medicine·Johan D BootZuzana Diamant
Apr 7, 2007·Biochemical and Biophysical Research Communications·Romy FischerProsper N Boyaka
Mar 21, 2008·Trends in Pharmacological Sciences·Meindert DanhofRob A Voskuyl
Jan 7, 2010·Therapeutic Advances in Respiratory Disease·John A MarwickIan M Adcock
Feb 18, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Alessandra GhigoEmilio Hirsch
Jun 11, 2010·International Archives of Allergy and Immunology·Masahide TakedaJunichi Chihara
Jun 15, 2010·Current Opinion in Pharmacology·Alexandra Wendler, Martin Wehling
Aug 4, 2011·BMC Pulmonary Medicine·Renata RamalhoAndré Moreira
Jul 31, 2013·American Journal of Respiratory Cell and Molecular Biology·Lily Y MoyMichael A Crackower
Aug 21, 2013·Biochemical Pharmacology·Paul McGonigle, Bruce Ruggeri
Aug 27, 2013·Nature Reviews. Drug Discovery·Peter J Barnes
Dec 17, 2014·Biochimica Et Biophysica Acta·P T Hawkins, L R Stephens
Mar 10, 2015·American Journal of Respiratory and Critical Care Medicine·Alan Chen-Yu HsuPhilip M Hansbro
Apr 1, 2015·European Journal of Pharmacology·Kay McNameeMichael Seed
Jun 21, 2015·Current Opinion in Pharmacology·Anne-Katrien StarkKlaus Okkenhaug
Jul 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michiko HoriguchiChikamasa Yamashita
Sep 8, 2015·The Journal of Allergy and Clinical Immunology·Peter J Barnes
Nov 6, 2015·Journal of the American Society of Nephrology : JASN·Mark de CaesteckerUNKNOWN ASN AKI Advisory Group
Dec 3, 2015·Postgraduate Medical Journal·Preet Mohinder SinghBasavana Goudra
Feb 27, 2016·The Journal of Allergy and Clinical Immunology·Friedrich HorakAlbert Yu
Mar 5, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Bryan DoAmber Rexwinkle
Mar 31, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chris GraingeFanny W S Ko
Apr 12, 2016·Journal of Paediatrics and Child Health·Colin Ve Powell
May 18, 2016·The Lancet. Respiratory Medicine·MeiLan K HanMark T Dransfield
Nov 2, 2016·The Lancet. Respiratory Medicine·Lowie E G W VanfleterenFrits M E Franssen
Apr 17, 2018·Journal of Cellular and Molecular Medicine·Wenhui CuiJian Gao
Dec 14, 2018·Nature Communications·Carlo C CampaEmilio Hirsch
Dec 26, 2018·Journal of Medicinal Chemistry·Matthew W D PerryAnnika Westin Eriksson

❮ Previous
Next ❯

Citations

Sep 26, 2020·Frontiers in Immunology·Giuseppe PalmaGerardo Botti
Apr 3, 2021·Journal of Medicinal Chemistry·Joey L MethotJason D Katz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.